Using longitudinal MRI radiomics, biochemical biomarkers, and clinical factors improves prediction of progression in knee OA.

The overall discontinuation rate of medical cannabis use was 57.9% at 1 year among patients with musculoskeletal pain.

BoneXpert and IB-lab-PANDA demonstrated accurate bone age evaluations against manual ratings among pediatric patients with GHD.

The ACR recently issued the first formal international consensus guidance statement on diagnosing and managing VEXAS syndrome ...

Cemdisiran is a subcutaneously-administered, small interfering RNA therapeutic that reduces the production of complement factor 5 in the liver.

Interquartile range increase in the cumulative exposure to heatwaves were associated with 0.023- to 0.031-year increases in biological age.

Very abnormal laboratory results were often already known or suspected or thought to be unrelated to DMARD use in RA.